|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Illumina
|
|
gptkbp:acquisitionYear
|
2021
|
|
gptkbp:CEO
|
gptkb:Bob_Ragusa
|
|
gptkbp:collaboratesWith
|
gptkb:NHS_England
|
|
gptkbp:focusesOn
|
liquid biopsy
early cancer detection
|
|
gptkbp:foundedYear
|
2016
|
|
gptkbp:founder
|
gptkb:Illumina
gptkb:Jeff_Huber
|
|
gptkbp:fundingRounds
|
multiple
|
|
gptkbp:headquartersLocation
|
gptkb:Menlo_Park,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Grail Bio
|
|
gptkbp:industry
|
gptkb:biotechnology
healthcare
|
|
gptkbp:market
|
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:mission
|
detect cancer early, when it can be cured
|
|
gptkbp:notableInvestment
|
gptkb:Bill_Gates
gptkb:Jeff_Bezos
gptkb:Illumina
gptkb:Arch_Venture_Partners
gptkb:Johnson_&_Johnson_Innovation
|
|
gptkbp:notableProduct
|
gptkb:Galleri
|
|
gptkbp:numberOfEmployees
|
1000+
|
|
gptkbp:parentCompany
|
gptkb:Illumina
|
|
gptkbp:productType
|
multi-cancer early detection test
|
|
gptkbp:regulates
|
laboratory developed test (LDT)
|
|
gptkbp:trial
|
NHS-Galleri trial
|
|
gptkbp:website
|
https://grail.com
|
|
gptkbp:bfsParent
|
gptkb:Sven_Strohband
|
|
gptkbp:bfsLayer
|
8
|